CLINICAL PHARMACOKINETICS OF RIFAMPICIN IN PATIENTS WITH TUBERCULOSIS AND TYPE 2 DIABETES MELLITUS: ASSOCIATION WITH BIOCHEMICAL AND IMMUNOLOGICAL PARAMETERS
Medellín-Garibay, S. E., Cortez-Espinosa, N, Milán-Segovia, R. C., Magaña-Aquino, M, Vargas-Morales, J. M., González-Amaro, R, Portales-Pérez, D. P., Romano-Moreno, SLanguage:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.01067-15
Date:
October, 2015
File:
PDF, 846 KB
english, 2015